Difference between revisions of "Team:UNITN-Trento/Results"

(v 0.1)
Line 4: Line 4:
 
 
 
</html>{{UNITN-Trento/globalIncluder}}<html>
 
</html>{{UNITN-Trento/globalIncluder}}<html>
−
<script src="https://2015.igem.org/Template:UNITN-Trento/JSModernizer?action=raw&ctype=text/javascript"></script>
 
−
<script src="https://2015.igem.org/Template:UNITN-Trento/JSscrollTo?action=raw&ctype=text/javascript"></script>
 
 
   
 
   
 
<div id="super_wrap">  
 
<div id="super_wrap">  
Line 14: Line 12:
 
<header id="header"></html>
 
<header id="header"></html>
 
{{UNITN-Trento/mainMenu}}
 
{{UNITN-Trento/mainMenu}}
−
<html><script>jQuery('#menulin_project, #menulin_project_results').addClass('current');
+
<html><script>jQuery('#menulin_project, #menulin_project_description').addClass('current');</script></header>
−
</script></header>
+
 
<!-- Main -->
 
<!-- Main -->
 +
<style>.faabig:before,.faabig:after{font-size:1.8em; margina:0;} .faabig{position:absolute; right:0; top:0.9em;} .header4{position:relative; border:0 !important;} .header4 > span {  border-bottom: 1px dotted #AAA;  display: block;  padding-bottom: 5px;  margin-right: 1.7em;}</style>
 
 
−
<section id="cta" data-stellar-background-ratio="0.4" style="background-image:url('https://static.igem.org/mediawiki/2015/8/89/Unitn_pics_cta_notebook.jpg');">
+
 +
<section id="cta" style="background-image:url('https://static.igem.org/mediawiki/2015/c/ca/Unitn_pics_cta_projectresults.jpg');" >
 
<header>
 
<header>
−
<h2><strong>TITLE OF THE SECTION</strong></h2>
+
<h2><strong>Results</strong></h2>  
−
<p> ? </p>
+
 
</header>
 
</header>
 +
<footer>
 +
<ul class="buttons">
 +
<li><p id="interlab_intro_btn" class="button small bstyle1" style="line-height:2em;" onclick="javascript:scrollToID('results_pncb')"><span class="primary">pncB</span> <span class="secondary">NAD Booster</span></p></li> 
 +
</ul>
 +
</footer>
 
</section>
 
</section>
 
 
−
<article id="main">  
+
 
−
<section class="wrapper style1 container special" style="margin-top:3em;">
+
<article id="main">
−
<div class="row">
+
−
Work in progress!
+
<a class="anchor-off" name=" " id=" "></a>
−
</div>
+
−
</section>
+
−
+
 
<section class="wrapper style4 container" style="margin-top:1em;">
 
<section class="wrapper style4 container" style="margin-top:1em;">
 
<!-- Content -->
 
<!-- Content -->
 
<div class="content">
 
<div class="content">
−
Work in progress!
+
<header>
−
</div>  
+
<h3 class="wow fadeInDown">Introduction to the Results</h3>
 +
</header>
 +
</div>
 
</section>
 
</section>
 
 
 +
<a class="anchor-off" name="results_pncb" id="results_pncb"></a>
 +
<section class="wrapper style4 container">
 +
<!-- Content -->
 +
<div class="content">
 +
<header>
 +
<h3 class="wow fadeInDown">Pnc<span class="bigletter">B</span>: nicotinic acid phosphorbosyl-transferase</h3>
 +
</header> 
 +
 +
<div class="row" >
 +
<div class="6u 12u(narrower)  wow fadeInLeft">
 +
<h4 class="header4 wow flipInX delay05"><span>Increasing the levels of NADH</span> <i class="faabig flaticon-bacteria3"></i></h4>
 +
 +
<p style="clear:both;">Our goal was to boost electron production by increasing the concentration of electron carriers (i.e. NADH). To achieve this goal we decided to engineer <span class="i_enph italic">E. coli</span> with an enzyme that would provide more intracellular NAD, and thus NADH.</p>
 +
<p>PncB catalyzes one of the rate-limiting step in the NAD synthesis pathway. This gene is naturally found in <span class="i_enph italic">E. coli</span> and encodes for the enzyme <span class="i_enph">NAPRTase</span> (nicotinic acid phosphorbosyl- transferase) that catalyzes the formation of nicotinate mono-nucleotide, a direct precursor of NAD, from NA (nicotinic acid).</p>
 +
<p style="text-align:center;">
 +
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/0/00/Unitn_pics_pncb_path.jpg"><img src="https://static.igem.org/mediawiki/2015/2/2e/Unitn_pics_pncb_path_thumb.jpg" alt="" style="width:100%; max-width:700px;"/></a>
 +
</p>
 +
<p>Our device is controlled by an inducible arabinose promoter built by the <a href="http://parts.igem.org/Part:BBa_K731201" class="i_linker" target="_blank">Unitn iGEM team in 2012</a>. PncB was extracted by <span class="i_enph italic">E. coli</span> genome, the illegal site PstI was removed, and it was placed in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K1604030" class="i_linker" target="_blank">BBa_K1604030</a>). Subsequently it was placed under the araC-pBAD promoter (<a href="http://parts.igem.org/Part:BBa_K1604031" class="i_linker" target="_blank">BBa_K1604030</a>).</p>
 +
</div>
 +
 +
<div class="6u 12u(narrower) wow fadeInLeft">
 +
<h4 class="header4 wow flipInX delay05"> <span>PncB is not toxic if overexpressed in <span style="font-style:italic">E.coli</span></span> <i class="faabig flaticon-atom27"></i></h4>
 +
<p style="clear:both;">
 +
NEB10&beta; transformed with <a href="http://parts.igem.org/Part:BBa_K1604031" class="i_linker" target="_blank">BBa_K1604030</a> (araC-pBAD-pncB) or <a href="http://parts.igem.org/Part:BBa_K731201" class="i_linker" target="_blank">BBa_K731201</a>  (i.e. araC-pBAD) were grown up to an OD of 0.6, splitted in two tubes of 23 mL each and induced  with 5 mM of arabinose. Negative controls were not induced.
 +
</p>
 +
<p>The OD (600 nm) was measured  every 45 minutes for 5 hours.  All measurements were done for 3 different biological samples and 3 technical measures.
 +
</p>
 +
 +
<p style="text-align:center;">
 +
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/c/ce/Unitn_pics_pncb_ToxicityTestPncB.png" title="Growth rate of BBa_K1604031 (aracpbad-pncb) and BBa_K731201 (i.e. aracpBad). Cells were grown up to an OD of 0.6 and splitted before induction with arabinose. BBa_K1604031 (Orange line) and BBa_K731201 (green line) induced with 5 mM arabinose. BBa_K1604031 (yellow line) and BBa_K731201 (blue line) not induced."><img src="https://static.igem.org/mediawiki/2015/2/21/Unitn_pics_pncb_ToxicityTestPncB_thumb.jpg" alt="" style="width:100%; max-width:700px;"/></a>
 +
</p>
 +
 +
<p>Although the growth rate is slightly decreased, due to the cell stress when expressing pncB, the data indicate that this enzyme does not have toxicity effect on the cells.</p>
 +
</div>
 +
</div>
 +
 +
<div class="row">
 +
<div class="12u 12u(narrower) wow fadeIn">
 +
<h4 class="header4 wow flipInX delay05"> <span>PncB enhances NAD production by ~2.5 fold</span><i class="faabig flaticon-chemistry33"></i></h4>
 +
</div>
 +
</div>
 +
<div class="row">
 +
<div class="6u 12u(narrower) wow fadeInLeft">
 +
<p style="clear:both;">Our goal was to demonstrate that pncB increased intracellular levels of NAD and thus NADH. We quantified the levels of NAD by a colorimetric test that measures the levels of NAD indirectly by quantifying the concentration of NAD total (NAD + NADH) and NADH only. To make precise quantitation a standard curve with NADH was built. The test provides the ratio of NAD/NADH</p>
 +
<p>NAD<sub>total</sub> = Amount of total NAD (NAD+NADH) in unknown sample (pmole) from standard curve.<br />
 +
NADH = Amount of NADH in unknown sample (pmole) from standard curve.</p>
 +
</div>
 +
 +
<div class="6u 12u(narrower) wow fadeInLeft centered">
 +
<p style="text-align:center;">
 +
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/4/45/Unitn_pics_pncb_StarndarRatioPncB.png" title="NAD and NADH levels were quantified with Sigma NAD /NADH quantification kit (MAK037)  following the instructions described in the technical bulletin. Panel A: Standard curve (0, 20, 40, 60,  80, 100 pmole/well of NADH)). Panel B: NAD/NADH levels for three biological samples of  BBa_K1604030 (green) and one negative control BBa_K731201 (blue). The cells were grown as  described previously."><img src="https://static.igem.org/mediawiki/2015/5/5e/Unitn_pics_pncb_StarndarRatioPncB_thumb.png" alt="" style="width:100%; max-width:700px;"/></a>
 +
</p>
 +
</div>
 +
</div>
 +
 +
<div class="row">
 +
 +
<div class="4u 12u(narrower) wow fadeInRight  centered">
 +
<p>
 +
<a class="fancybox" rel="group" href="https://static.igem.org/mediawiki/2015/2/26/Unitn_pics_pncb_wells.jpg" title="Lane B samples 2-7 calibration curve (0, 20, 40, 60, 80, 100 pmole/well of NADH). Lane C    samples 2-9 NAD total levels; Lane D samples 2-9 NAD total repeated with a 2 fold concentrated    sample; Lane E NADH only; Lane F NADH only, repeated with a 2 fold concentrated sample. In    lanes C-F the order of the samples is: 2 technical replicates of the negative control, and 2 technical    replicates of each of the 3 biological samples of BBa_K1604031. The plate was read with a Tecan    Infinite M-200 pro instrument at 450 nm. The measurements were taken after 0.5, 1, 2, 3, 4 hours    to allow color development. The data shown are representative of the best measurement at 2    hours."><img src="https://static.igem.org/mediawiki/2015/1/1b/Unitn_pics_pncb_wells_thumb.jpg" alt="" style="width:100%; max-width:500px;"/></a>
 +
</p>
 +
</div>
 +
 +
<div class="8u 12u(narrower) wow fadeInRight">
 +
<p>BBa_K1604031 does increase NAD levels by <span class="i_enph">126%</span> (2.5 fold) and NADH levels by  <span class="i_enph">44%</span> (1.4 fold)    when expressed in NEB10&beta;. Although we did see an enhancement in NAD levels, this did not    correlate to a proportional boost in NADH levels. We plan in the future to add a NAD reducing    enzyme and to give a medium able to enhance the cell metabolism to further increase NADH    intracellular levels.</p>
 +
</div>
 +
</div>
 +
</div>
 +
</section> 
 
</article>
 
</article>
  
Line 48: Line 119:
  
 
<!-- Scripts -->  
 
<!-- Scripts -->  
 +
<script>$(function()
 +
{new WOW().init();
 +
$(".fancybox").fancybox({});
 +
});
 +
</script>
 
</div>
 
</div>
 
</div>
 
</div>
 
</html>
 
</html>

Revision as of 15:35, 5 September 2015

Results

  • pncB NAD Booster

Introduction to the Results

PncB: nicotinic acid phosphorbosyl-transferase

Increasing the levels of NADH

Our goal was to boost electron production by increasing the concentration of electron carriers (i.e. NADH). To achieve this goal we decided to engineer E. coli with an enzyme that would provide more intracellular NAD, and thus NADH.

PncB catalyzes one of the rate-limiting step in the NAD synthesis pathway. This gene is naturally found in E. coli and encodes for the enzyme NAPRTase (nicotinic acid phosphorbosyl- transferase) that catalyzes the formation of nicotinate mono-nucleotide, a direct precursor of NAD, from NA (nicotinic acid).

Our device is controlled by an inducible arabinose promoter built by the Unitn iGEM team in 2012. PncB was extracted by E. coli genome, the illegal site PstI was removed, and it was placed in pSB1C3 (BBa_K1604030). Subsequently it was placed under the araC-pBAD promoter (BBa_K1604030).

PncB is not toxic if overexpressed in E.coli

NEB10β transformed with BBa_K1604030 (araC-pBAD-pncB) or BBa_K731201 (i.e. araC-pBAD) were grown up to an OD of 0.6, splitted in two tubes of 23 mL each and induced with 5 mM of arabinose. Negative controls were not induced.

The OD (600 nm) was measured every 45 minutes for 5 hours. All measurements were done for 3 different biological samples and 3 technical measures.

Although the growth rate is slightly decreased, due to the cell stress when expressing pncB, the data indicate that this enzyme does not have toxicity effect on the cells.

PncB enhances NAD production by ~2.5 fold

Our goal was to demonstrate that pncB increased intracellular levels of NAD and thus NADH. We quantified the levels of NAD by a colorimetric test that measures the levels of NAD indirectly by quantifying the concentration of NAD total (NAD + NADH) and NADH only. To make precise quantitation a standard curve with NADH was built. The test provides the ratio of NAD/NADH

NADtotal = Amount of total NAD (NAD+NADH) in unknown sample (pmole) from standard curve.
NADH = Amount of NADH in unknown sample (pmole) from standard curve.

BBa_K1604031 does increase NAD levels by 126% (2.5 fold) and NADH levels by 44% (1.4 fold) when expressed in NEB10β. Although we did see an enhancement in NAD levels, this did not correlate to a proportional boost in NADH levels. We plan in the future to add a NAD reducing enzyme and to give a medium able to enhance the cell metabolism to further increase NADH intracellular levels.